Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-25 4:10 pm Sale | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 2,255,719 2.7% | -4,074,829 (-64.37%) | View |
| 2023-04-28 4:08 pm Unchanged | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 6,330,548 7.9% | 0 (Unchanged) | View |
| 2023-02-06 2:56 pm Sale | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 6,330,548 7.9% | -12,000,000 (-65.46%) | View |
| 2022-12-22 7:30 pm Unchanged | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 18,330,548 23.8% | 0 (Unchanged) | View |
| 2022-12-09 4:06 pm Sale | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 18,330,548 23.8% | -3,088,182 (-14.42%) | View |
| 2022-12-08 09:07 am Sale | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 21,418,730 27.8% | -775,000 (-3.49%) | View |
| 2020-10-13 5:26 pm Sale | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 22,193,730 28.9% | -1,400,000 (-5.93%) | View |
| 2020-05-29 11:54 am Purchase | 13D | ADC Therapeutics SA ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 23,593,730 33.4% | 23,593,730 (New Position) | View |